Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of escitalopram treatment in acute stroke and the role of SERT genotype
2011-005541-12Phase 4Terminated
- Sponsor
- Grethe Andersen
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of escitalopram in ischemic stroke, stroke and myocardial infarction (MI), sponsored by Grethe Andersen. Primary endpoint: Combined vascular mortality. Started Feb 2012; status: terminated.
02
Drugs
escitalopram
03
Conditions
ischemic strokestrokemyocardial infarction (MI)
Beyond the preview
Go deeper on 2011-005541-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005541-12.